WELCOME TO The HEALTHCARE REPORT
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
iXensor | September 14, 2021
iXensor, the pioneer of mobile health, launches its new Eveline•Care service, effectively turning the smartphone-based Eveline Ovulation Predictor Kit (OPK) into a telehealth-enabled fertility monitoring system. This telehealth service is anticipated by OB-GYN practitioners and highly appreciated by patients for comfortable at-home testing, especially amid the ongoing COVID-19 pandemic globally.
Helping couples to conceive all around the world<...
GeneQuantum Healthcare | May 16, 2022
GeneQuantum Healthcare Co., Ltd. a global innovative biotechnology company dedicated to the development of bioconjugate drugs, announced that two of the company's bioconjugate drug candidates have won the approval for clinical trials in Australia, further enhancing GeneQuantum's pipelines in the clinical stage. They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugateboth with global intellectual property r...
HIT Consultant | March 13, 2020
The Bill & Melinda Gates Foundation, Wellcome and Mastercard announced the launch of the COVID-19 Therapeutics Accelerator with a committed $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. While antiviral drugs are approved to lessen the severity of seasonal flu and treat HI...
Healthcare IT News | April 02, 2020
When healthcare experts in Europe started debating whether or not to reimburse digital health applications two years ago, Josef Hecken, a very senior German health politician, said in an interview that health insurance companies should not be obliged to pay for “fun applications”. Hecken is head of the German healthcare system’s governing board for reimbursement decisions (G-BA). He is among those who really has a say on where the money flows in German healthcare. Quotes ...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE